Insomnia News and Research

Latest Insomnia News and Research

Association between gastrointestinal disorders and sleep disturbances

Mayo Clinic researchers report in the current issue of Mayo Clinic Proceedings an association between gastrointestinal disorders and sleep disturbances. The association is important because these problems cause significant health issues including greater need for general medical and mental health treatment.

13 Dec 2004

New class of drugs to repair psychiatric disorders

“Smart” drugs capable of targeting specific brain cells to control psychiatric disorders such as autism and schizophrenia may be ready for early clinical trials within three years, with the launch of a $1.5 million project to take place at the Brain Research Centre (BRC)

29 Nov 2004

Effective management of insomnia begins with recognition and adequate assessment

A seminar in this week’s issue of THE LANCET outlines the common but poorly understood condition of insomnia, concluding that awareness and assessment of insomnia by family doctors is a priority.

29 Nov 2004

Highly obese women are 12 times more likely to have diabetes

Highly obese women are 12 times more likely to have diabetes or knee replacement surgery, and five times more likely to have high blood pressure than women who are at a normal weight, says a new study.

23 Nov 2004

New research could address sleep problems associated with alcohol

New research about how alcohol affects sleep could lead to medications to address a common reason some alcoholics go back to drinking – disturbed sleep when they try to stop.

28 Oct 2004

Many patients with sleep apnea or insomnia also have attention deficit disorder

People who have difficulty sleeping at night or staying awake during the day may suffer from more than just a sleep disorder.

25 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Women should aim for half an hour’s gentle exercise three times a week to aid their recovery from breast cancer

Currently the standard treatment for breast cancer involves no exercise therapy. However, the initial findings from a Cancer Research UK trial has shown that exercise therapy and lifestyle counselling could hasten recovery and improve the long-term physical and mental well being of women who are recovering from breast cancer.

8 Oct 2004

Minor depression is effectively treated with medication

Minor depression, an underdiagnosed and undertreated subset of major depressive disorder that affects upwards of 15 million Americans, can be effectively treated with a drug called a selective serotonin reuptake inhibitor (SSRI)

5 Oct 2004

Pregnant women are at higher risk for restless legs syndrome

Pregnant women are at higher risk for the occurrence or worsening of restless legs syndrome (RLS), a movement disorder that affects up to 10 percent of the general population, according to a study reported in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

27 Sep 2004

New drug application to market ramelteon for insomnia

Takeda Global Research & Development Center announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to market ramelteon (TAK-375), its investigational drug for insomnia.

26 Sep 2004

Histamine is key to narcolepsy

Narcolepsy is a disorder of sleep regulation that affects control of wakefulness and sleep and renders the patient subject to disabling sleepiness during the day.

23 Sep 2004

Prozac, Paxil, Wellbutrin, Zoloft, Celexa, Effexor, Luvox and Remeron should have "Black Box" warnings

A panel of experts has voted 15 to 8 in favour of the Federal Food and Drug Administration (FDA) adding black box warnings to certain medications used to treat depression in children and teenagers.

14 Sep 2004

Yentreve available in Europe for treatment of stress urinary incontinence

Yentreve (duloxetine hydrochloride) is now available in certain European countries, giving women suffering from moderate to severe stress urinary incontinence (SUI) a pharmaceutical treatment option for the first time.

13 Sep 2004

Lack of sleep may cause behavioral, learning and attention problems

Nine-year-old Fernando Perry-Mendoza may no longer need medication for attention-deficit/hyperactivity disorder thanks to the results of a sleep study at Doernbecher Children’s Hospital’s new Pediatric Sleep Program.

1 Sep 2004

Newly discovered protein switch may be key to understanding sleep disorders, anxiety, and depression

University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.

18 Aug 2004